Diese Aktie gehört wohl zu den günstigsten Biotechs überhaupt aber am besten macht eure Hausaufgaben selbst und ihr werdet staunen .
Hier hat man die Chance wirklich sehr gutes geld zu verdienen .
IntelliPharmaceutics (IPCI)
Marktkap: 17 Mio$
Cash: 8 Mio$
Kurs: 1,50 $
Shares Out: 10,9 M
Pipeline
www.intellipharmaceutics.com/pipeline.cfm
Präsentation März 2010
files.shareholder.com/downloads/...b7/Intellipharmaceutics.pdf
Intellipharmaceutics' development milestones for 2010 include the following:
-- Potential conclusion of the ongoing litigation process and/or FDA
approval of Focalin XR
-- File and have accepted for review by the FDA, two additional ANDA applications
-- Establish at least one additional development/marketing alliance
-- Complete successful manufacturing of clinical batches of Rexista(TM)
-- Complete Phase 1 studies using clinical batches of Rexista(TM)
-- Schedule a pre-IND meeting with FDA to discuss Rexista(TM) clinical
development plan
Hier hat man die Chance wirklich sehr gutes geld zu verdienen .
IntelliPharmaceutics (IPCI)
Marktkap: 17 Mio$
Cash: 8 Mio$
Kurs: 1,50 $
Shares Out: 10,9 M
Pipeline
www.intellipharmaceutics.com/pipeline.cfm
Präsentation März 2010
files.shareholder.com/downloads/...b7/Intellipharmaceutics.pdf
Intellipharmaceutics' development milestones for 2010 include the following:
-- Potential conclusion of the ongoing litigation process and/or FDA
approval of Focalin XR
-- File and have accepted for review by the FDA, two additional ANDA applications
-- Establish at least one additional development/marketing alliance
-- Complete successful manufacturing of clinical batches of Rexista(TM)
-- Complete Phase 1 studies using clinical batches of Rexista(TM)
-- Schedule a pre-IND meeting with FDA to discuss Rexista(TM) clinical
development plan